{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:17:41Z","timestamp":1787026661257,"version":"build-2736575974"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Decreased light transmittance through the ocular lens, termed cataract, is a leading cause of low vision and blindness worldwide. Cataract causes significantly decreased quality of life, particularly in the elderly. Environmental risk factors, including aging, UV exposure, diabetes, smoking and some prescription drugs, are all contributors to cataract formation. In particular, drug-induced cataract represents a poorly-addressed source of cataract. To better understand the potential impact of prescription drugs on cataract, we analyzed publicly-available drug prescriptions data from the Australian Pharmaceutical Benefits Scheme. The data was analyzed for the 5-year period from July 2014 to June 2019. Analyses included the number of prescriptions for each drug, as well as the associated government and total prescription costs. The drugs chosen for analysis belonged to any of four broad categories\u2014those with known, probable, possible or uncertain association with cataract in patients. The analyses revealed high prescription rates and costs for drugs in the Known category (e.g., steroids) and Possible category (e.g., psychotropic drugs). Collectively, these data provide valuable insights into specific prescription drugs that likely contribute to the increasing annual burden of new cataract cases. These data highlight the need\u2014as well as new, stem cell-based opportunities\u2014to elucidate molecular mechanisms of drug-induced cataract formation.<\/jats:p>","DOI":"10.3389\/fmed.2022.947659","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:31:03Z","timestamp":1660523463000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Drugs associated with cataract formation represent an unmet need in cataract research"],"prefix":"10.3389","volume":"9","author":[{"given":"Jack","family":"Carlson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,15]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis.","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Glob Health."},{"key":"B2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/B978-0-323-31984-3.00005-2","author":"Fraunfelder","year":"2014","journal-title":"Drug-Induced Ocular Side Effects."},{"key":"B3","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ophtha.2008.12.001","article-title":"Use of inhaled and oral corticosteroids and the long-term risk of cataract.","volume":"116","author":"Wang","year":"2009","journal-title":"Ophthalmology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4103\/tjo.tjo_68_19","article-title":"Corticosteroids for diabetic macular edema.","volume":"9","author":"Chawan-Saad","year":"2019","journal-title":"Taiwan J Ophthalmol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1136\/flgastro-2018-101083","article-title":"G-Eye: ocular manifestations of gastrointestinal disease.","volume":"11","author":"Imam","year":"2020","journal-title":"Frontline Gastroenterol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/qjmed\/93.2.105","article-title":"Use of oral corticosteroids in the United Kingdom.","volume":"93","author":"van Staa","year":"2000","journal-title":"QJM."},{"key":"B7","doi-asserted-by":"publisher","first-page":"j1415","DOI":"10.1136\/bmj.j1415","article-title":"Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study.","volume":"357","author":"Waljee","year":"2017","journal-title":"BMJ."},{"key":"B8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/rheumatology\/keh088","article-title":"Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review.","volume":"43","author":"Whittle","year":"2004","journal-title":"Rheumatology (Oxford)."},{"key":"B9","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1089\/jop.2006.0067","article-title":"The etiology of steroid cataract.","volume":"23","author":"James","year":"2007","journal-title":"J Ocul Pharmacol Ther."},{"key":"B10","first-page":"364","article-title":"Human posterior subcapsular cataracts.","volume":"102","author":"Eshagian","year":"1982","journal-title":"Trans Ophthalmol Soc U K."},{"key":"B11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1006\/exer.1997.0359","article-title":"Steroid-induced cataract: new perspective from in vitro and lens culture studies.","volume":"65","author":"Dickerson","year":"1997","journal-title":"Exp Eye Res."},{"key":"B12","first-page":"1018","article-title":"Global gene profiling reveals novel glucocorticoid induced changes in gene expression of human lens epithelial cells.","volume":"11","author":"Gupta","year":"2005","journal-title":"Mol Vis."},{"key":"B13","first-page":"64","article-title":"Matrix metalloproteinase\u20132 and \u20139 activities in the human lens epithelial cells and serum of steroid induced posterior subcapsular cataracts.","volume":"18","author":"Alapure","year":"2012","journal-title":"Mol Vis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1167\/iovs.06-0889","article-title":"Specific activation of the glucocorticoid receptor and modulation of signal transduction pathways in human lens epithelial cells.","volume":"48","author":"Gupta","year":"2007","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2174\/1874364101206010042","article-title":"Cell adhesion molecule expression in human lens epithelial cells after corticosteroid exposure.","volume":"6","author":"Celojevic","year":"2012","journal-title":"Open Ophthalmol J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1039\/c1mb05045a","article-title":"Glucocorticoid receptors take part in the apoptotic process of human lens epithelial cells, but the glucocorticoid receptor antagonist RU486 does not rescue the cells fully.","volume":"7","author":"Wang","year":"2011","journal-title":"Mol Biosyst."},{"key":"B17","first-page":"1344","article-title":"Effects of dexamethasone on human lens epithelial cells in culture.","volume":"14","author":"Petersen","year":"2008","journal-title":"Mol Vis."},{"key":"B18","year":"2021","journal-title":"Australian Institute of Health and Welfare."},{"key":"B19","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ajo.2014.03.006","article-title":"Selective serotonin reuptake inhibitor use and increased risk of cataract surgery: a population-based, case-control study.","volume":"158","author":"Erie","year":"2014","journal-title":"Am J Ophthalmol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.ophtha.2009.11.042","article-title":"Selective serotonin reuptake inhibitors and the risk of cataracts: a nested case-control study.","volume":"117","author":"Etminan","year":"2010","journal-title":"Ophthalmology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jad.2017.03.044","article-title":"Antidepressants and risk of cataract development: a population-based, nested case-control study.","volume":"215","author":"Chou","year":"2017","journal-title":"J Affect Disord."},{"key":"B22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12886-018-0699-0","article-title":"Antidepressants use and risk of cataract development: a systematic review and meta-analysis.","volume":"18","author":"Fu","year":"2018","journal-title":"BMC Ophthalmol."},{"key":"B23","first-page":"152","article-title":"Levels of norepinephrine, epinephrine, dopamine, serotonin and N-acetylserotonin in aqueous humour.","volume":"22","author":"Trope","year":"1987","journal-title":"Can J Ophthalmol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/BF00157004","article-title":"Serotonin (5-HT) and the rat\u2019s eye. Some pilot studies.","volume":"82","author":"Boerrigter","year":"1992","journal-title":"Doc Ophthalmol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/s0306-4522(98)00181-x","article-title":"Localization of 5-hydroxytryptamine1A and 5-hydroxytryptamine7 receptors in rabbit ocular and brain tissues.","volume":"87","author":"Chidlow","year":"1998","journal-title":"Neuroscience."},{"key":"B26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3109\/02713688909013899","article-title":"Evidence for the presence of phosphoinositide cycle and its involvement in cellular signal transduction in the rabbit lens.","volume":"8","author":"Vivekanandan","year":"1989","journal-title":"Curr Eye Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cell.2015.01.036","article-title":"A century of cholesterol and coronaries: from plaques to genes to statins.","volume":"161","author":"Goldstein","year":"2015","journal-title":"Cell."},{"key":"B28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10557-018-6794-x","article-title":"A 10-Year trend in statin use among older adults in australia: an analysis using national pharmacy claims data.","volume":"32","author":"Ofori-Asenso","year":"2018","journal-title":"Cardiovasc Drugs Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"E1083","DOI":"10.3390\/nu11051083","article-title":"Why is very high cholesterol content beneficial for the eye lens but negative for other organs?","volume":"11","author":"Widomska","year":"2019","journal-title":"Nutrients."},{"key":"B30","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1006\/exer.1998.0465","article-title":"Cholesterol oxides accumulate in human cataracts.","volume":"66","author":"Gir\u00e3o","year":"1998","journal-title":"Exp Eye Res."},{"key":"B31","first-page":"494","article-title":"Cataracts produced by triparanol. (MER-29).","volume":"65","author":"Kirby","year":"1967","journal-title":"Trans Am Ophthalmol Soc."},{"key":"B32","doi-asserted-by":"publisher","first-page":"6230","DOI":"10.1016\/S0021-9258(18)83338-5","article-title":"Inhibition of cholesterol synthesis and cell growth by 24(R,S),25-iminolanosterol and triparanol in cultured rat hepatoma cells.","volume":"264","author":"Popj\u00e1k","year":"1989","journal-title":"J Biol Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/0039-128x(93)90056-s","article-title":"Effect of sterol biosynthesis inhibitor, SSF-109, on cholesterol synthesis in isolated rat hepatocytes.","volume":"58","author":"Seo","year":"1993","journal-title":"Steroids."},{"key":"B34","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nature14650","article-title":"Lanosterol reverses protein aggregation in cataracts.","volume":"523","author":"Zhao","year":"2015","journal-title":"Nature."},{"key":"B35","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1126\/science.aac9145","article-title":"Pharmacological chaperone for \u03b1-crystallin partially restores transparency in cataract models.","volume":"350","author":"Makley","year":"2015","journal-title":"Science."},{"key":"B36","doi-asserted-by":"publisher","first-page":"888","DOI":"10.4103\/0301-4738.176040","article-title":"Effect of lanosterol on human cataract nucleus.","volume":"63","author":"Shanmugam","year":"2015","journal-title":"Indian J Ophthalmol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"8459","DOI":"10.1038\/s41598-019-44676-4","article-title":"Failure of oxysterols such as lanosterol to restore lens clarity from cataracts.","volume":"9","author":"Daszynski","year":"2019","journal-title":"Sci Rep."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e12480","DOI":"10.1111\/1755-5922.12480","article-title":"Statins and risk of cataracts: a systematic review and meta-analysis of observational studies.","volume":"36","author":"Alves","year":"2018","journal-title":"Cardiovasc Ther."},{"key":"B39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1177\/1074248413511690","article-title":"Prevention of cataracts by statins: a meta-analysis.","volume":"19","author":"Kostis","year":"2014","journal-title":"J Cardiovasc Pharmacol Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/0002-9149(91)90002-3","article-title":"Expanded clinical evaluation of lovastatin (EXCEL) study results. II. Assessment of the human lens after 48 weeks of treatment with lovastatin.","volume":"67","author":"Laties","year":"1991","journal-title":"Am J Cardiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e004180","DOI":"10.1161\/JAHA.116.004180","article-title":"Statin use and the risk of cataracts: a systematic review and meta-analysis.","volume":"6","author":"Yu","year":"2017","journal-title":"J Am Heart Assoc."},{"key":"B42","year":"2017","journal-title":"The Economic Impact of Vision Problems."},{"key":"B43","doi-asserted-by":"publisher","first-page":"dev155838","DOI":"10.1242\/dev.155838","article-title":"Light-focusing human micro-lenses generated from pluripotent stem cells model lens development and drug-induced cataract in vitro.","volume":"145","author":"Murphy","year":"2018","journal-title":"Development."},{"key":"B44","doi-asserted-by":"publisher","first-page":"108317","DOI":"10.1016\/j.exer.2020.108317","article-title":"A simplified method for producing human lens epithelial cells and light-focusing micro-lenses from pluripotent stem cells.","volume":"202","author":"Dewi","year":"2021","journal-title":"Exp Eye Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3390\/cells8101269","article-title":"Use of human pluripotent stem cells to define initiating molecular mechanisms of cataract for anti-cataract drug discovery.","volume":"8","author":"Dewi","year":"2019","journal-title":"Cells."},{"key":"B46","doi-asserted-by":"publisher","first-page":"153064","DOI":"10.1016\/j.tox.2021.153064","article-title":"Evaluation of lens opacity due to inhibition of cholesterol biosynthesis using rat lens explant cultures.","volume":"465","author":"Miyashita","year":"2022","journal-title":"Toxicology."},{"key":"B47","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/scrt169","article-title":"The 3R principle: advancing clinical application of human pluripotent stem cells.","volume":"4","author":"O\u2019Connor","year":"2013","journal-title":"Stem Cell Res Ther."},{"key":"B48","year":"2021","journal-title":"PBS and RPBS Section 85 Date of Supply Data."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.947659\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:31:11Z","timestamp":1660523471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.947659\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,15]]},"references-count":48,"alternative-id":["10.3389\/fmed.2022.947659"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.947659","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,15]]},"article-number":"947659"}}